ArticleHepatology international2026
Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment.
Jiawei Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it